Study identifies biomarker for the onset & progression of MS

A board to discuss Low Dose Naltrexone (LDN) as a treatment for Multiple Sclerosis
Post Reply
User avatar
MSUK
Family Elder
Posts: 2903
Joined: Wed Oct 14, 2009 2:00 pm
Contact:
Contact MSUK

Study identifies biomarker for the onset & progression of MS

Post by MSUK »

A team of researchers have identified Opioid Growth Factor (OGF) as a novel biomarker for the onset and progression of multiple sclerosis (MS)...Read more - http://www.ms-uk.org/study-identifies-b ... ression-ms

Image
MS-UK - http://www.ms-uk.org/
Top
Post Reply

Return to “Low Dose Naltrexone”